Complementary Medicines Australia is proud to once again lead the Australian industry’s presence at Healthplex Expo 2025, Asia’s premier event for nutraceuticals and health foods. Taking place from 24–26 June 2025 in Shanghai, the Australian Pavilion will shine a spotlight on the strength, innovation, and quality of Australia’s complementary medicines sector.
Joining CMA in the Pavilion this year are CMA members:
- Blackmores
- Bluegum Pharmaceuticals
- Ferngrove Pharmaceuticals
- Homart Pharmaceuticals
- Lavida Pharmaceuticals
- Lipa Pharmaceuticals.
Thanks to support from Austrade, Investment NSW, and the Australian Made Campaign Limited, the Pavilion highlights the significance of Australia’s deep trade relationship with China — our largest export market for complementary medicines.
China remains a critical market for Australian natural health products, and Healthplex is a platform to strengthen these ties. With Australia’s reputation for high-quality, safe, and innovative products, the Pavilion serves as both a showcase and a strategic springboard for further growth in the region.
This year’s program includes a dynamic schedule designed to maximise opportunities for exhibitors, including an official opening ceremony, the Australian Pavilion launch, a B2B matchmaking lunch to foster new business partnerships, and a gala dinner, all delivered in collaboration with the China Chamber of Commerce (CCCMHPIE).
These events will provide invaluable networking and engagement opportunities, helping Australian brands to deepen relationships and expand their reach across China and the wider Asia-Pacific region.
We expect Healthplex 2025 to be a productive and energising three days in Shanghai, and CMA is proud to support our members in connecting with global markets.
